MEDICINE TO TREAT GASTRIC AND ESOPHAGEAL REFLUX BRAND: RABEBOSTON (BOX OF 2 BLISTER PACKS X 14 TABLETS) TP: RABEPRAZOLE SODIUM 20MG. LOT NUMBER: 011022 PRODUCTION DATE: OCTOBER 24 2022 EXPIRY DATE: OCTOBER 24 2025. 100% NEW#&VN
MEDICINE TO TREAT GASTRIC AND ESOPHAGEAL REFLUX BRAND: RABEBOSTON (BOX OF 2 BLISTER PACKS X 14 TABLETS) TP: RABEPRAZOLE SODIUM 20MG. LOT NUMBER: 011022 PRODUCTION DATE: OCTOBER 24 2022 EXPIRY DATE: OCTOBER 24 2025. 100% NEW#&VN
DRUGS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES: RABESTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOL SODIUM 20MG)#&VN
DRUGS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES: RABESTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOL SODIUM 20MG)#&VN
14-February-2023
3004909900
DRUGS FOR TREATING DIGESTIVE DISEASES: BESOSTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOLE SODIUM 20 MG)#&VN
DRUGS FOR TREATING DIGESTIVE DISEASES: BESOSTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOLE SODIUM 20 MG)#&VN
31-January-2023
3004909900
DRU.GS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES: RABESTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOL SODIUM 20MG)#&VN
DRU.GS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES: RABESTAD 20 (BOX OF 30V) (ACTIVE INGREDIENT: RABEPRAZOL SODIUM 20MG)#&VN
11-March-2022
2933399000
RABEPRAZOLE SODIUM. DRUG MANUFACTURING MATERIALS. 99% CONTENT. RE-EXPORT ACCORDING TO ITEM 1 DECLARATION 104042682111 (MAY 24 2021). THE COMPANY IS COMMITTED TO NOT PUTTING IN PROCESSING OR USING. # & IN
RABEPRAZOLE SODIUM. DRUG MANUFACTURING MATERIALS. 99% CONTENT. RE-EXPORT ACCORDING TO ITEM 1 DECLARATION 104042682111 (MAY 24 2021). THE COMPANY IS COMMITTED TO NOT PUTTING IN PROCESSING OR USING. # & IN